Cyclerion Therapeutics (CYCN) Shares Outstanding (Weighted Average) (2018 - 2025)

Cyclerion Therapeutics' Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $3.8 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 51.76% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (up 51.76% YoY), while the FY2025 annual figure was $3.8 million, up 51.76% from the prior year.
• Shares Outstanding (Weighted Average) was $3.8 million for Q4 2025 at Cyclerion Therapeutics, up from $3.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $39.1 million in Q4 2021 to a low of $43425.0 in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $9.2 million across 5 years, with a median of $2.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) tumbled 99.87% in 2022, then soared 4910.94% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $39.1 million in 2021, then slumped by 94.45% to $2.2 million in 2022, then advanced by 7.59% to $2.3 million in 2023, then advanced by 7.7% to $2.5 million in 2024, then soared by 51.76% to $3.8 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $3.8 million (Q4 2025), $3.0 million (Q3 2025), and $3.1 million (Q2 2025), per Business Quant data.